Autobio Diagnostics (603658.SH) and its subsidiaries have obtained multiple medical device registration certificates.
Antu Biology (603658.SH) announced that the company and its wholly-owned subsidiary Antu Experimental Instrument (Zhengzhou) Co., Ltd. ("Antu Instrument") recently received multiple medical device registration certificates issued by the Henan Provincial Drug Administration.
Autobio Diagnostics (603658.SH) announced that the company and its wholly-owned subsidiary, Antu Laboratory Instrument (Zhengzhou) Co., Ltd. (referred to as "Antu Instrument"), recently received multiple medical device registration certificates issued by the Henan Provincial Drug Administration.
The acquisition of the above-mentioned medical device registration certificates further enriches the company's product menu, continuously meeting market demand. It is an effective supplement to the company's existing testing products and can gradually improve the overall competitiveness of the company's products. In the short term, the impact on the company's operating performance is minimal.
Related Articles

A.PLUS GROUP (01841) released its interim financial results, with a net profit attributable to shareholders of HK$7.484 million, a decrease of 25.61% year-on-year.

C-MER MEDICAL (03309) spent HK$207,600 on November 27 to repurchase 120,000 shares.

Shenzhen Minkave Technology (300506.SZ) enters the stage of implementing the restructuring plan.
A.PLUS GROUP (01841) released its interim financial results, with a net profit attributable to shareholders of HK$7.484 million, a decrease of 25.61% year-on-year.

C-MER MEDICAL (03309) spent HK$207,600 on November 27 to repurchase 120,000 shares.

Shenzhen Minkave Technology (300506.SZ) enters the stage of implementing the restructuring plan.

RECOMMEND

Food Delivery Ceasefire: Chinese Concept Stocks Reach Dual Inflection In Value And Technology — From Cash‑Burning Rivalry To An AI‑Led Strategic Upgrade
27/11/2025

Six Departments Issue Joint Plan To Boost Consumption And Improve Supply‑Demand Alignment For Consumer Goods
27/11/2025

Citi Research On China’s Humanoid Robot Industry: Broad Optimism, Exponential Growth Likely In 2026, At Least A Doubling
27/11/2025


